250 related articles for article (PubMed ID: 9784559)
1. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.
Ascón MA; Hone DM; Walters N; Pascual DW
Infect Immun; 1998 Nov; 66(11):5470-6. PubMed ID: 9784559
[TBL] [Abstract][Full Text] [Related]
2. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
3. Partially assembled K99 fimbriae are required for protection.
Ascón MA; Ochoa-Repáraz J; Walters N; Pascual DW
Infect Immun; 2005 Nov; 73(11):7274-80. PubMed ID: 16239523
[TBL] [Abstract][Full Text] [Related]
4. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
[TBL] [Abstract][Full Text] [Related]
6. Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model.
Hur J; Kim CS; Eo SK; Park SY; Lee JH
Vet Q; 2015; 35(3):125-32. PubMed ID: 25853619
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99.
Wei CH; Liu JK; Hou XL; Yu LY; Lee JS; Kim CJ
Vaccine; 2010 May; 28(24):4113-8. PubMed ID: 19539580
[TBL] [Abstract][Full Text] [Related]
8. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
9. F41 pili as protective antigens of enterotoxigenic Escherichia coli that produce F41, K99, or both pilus antigens.
Runnels PL; Moseley SL; Moon HW
Infect Immun; 1987 Mar; 55(3):555-8. PubMed ID: 2880807
[TBL] [Abstract][Full Text] [Related]
10. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model.
Hur J; Lee JH
J Vet Med Sci; 2011 Oct; 73(10):1265-73. PubMed ID: 21628866
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
Hur J; Lee JH
Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
[TBL] [Abstract][Full Text] [Related]
13. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of a recombinant adenoviral based vaccine expressing heat-stable enterotoxin (STa) and K99 adhesion antigen of enterotoxigenic Escherichia coli in mice.
Deng G; Li W; Wu X; Bao S; Zeng J; Zhao N; Luo M; Liu X; Wang Y
Mol Immunol; 2015 Dec; 68(2 Pt C):684-91. PubMed ID: 26589454
[TBL] [Abstract][Full Text] [Related]
15. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
16. Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs.
Morona R; Morona JK; Considine A; Hackett JA; van den Bosch L; Beyer L; Attridge SR
Vaccine; 1994 May; 12(6):513-7. PubMed ID: 7913567
[TBL] [Abstract][Full Text] [Related]
17. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
Pascual DW; White MD; Larson T; Walters N
J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
[TBL] [Abstract][Full Text] [Related]
18. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW
Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
Łaniewski P; Baek CH; Roland KL; Curtiss R
mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
